Abstract
How should clinicians treat mood-disordered children who are at high risk for bipolar I disorder (BP-I)? Two recent studies address the question. The first study used “gold standard” methods of double-blinding, placebo control, and random assignment to study the effect of divalproex. The participants were 56 children (mean age, 10.8 years) considered at high risk for BP-I because they had one first-degree relative with bipolar disorder, were diagnosed with bipolar …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
